Bubs CEO: Market dynamics mean US infant formula sector will be as significant as China

By Tingmin Koe

10-Oct-2022 - Last updated on 10-Oct-2022 at 07:48 GMT

The CEO of infant formula maker Bubs Australia says that the market dynamics in the US has given the firm the confidence that it will become as significant as China.

Read the full story here.

NIA top 10 stories

Potential therapy: Vitamin B12 supplementation could improve NAFLD patient condition – RCT

Winners revealed: Find out who took the top prizes at this year's NutraIngredients Asia Awards!

'Specific Chinese needs': Nestle's Garden of Life launches two new probiotics for kids' growth and immune health

Dairy dynamic: Probiotic yoghurt could decrease heavy metal levels in blood – RCT

Profits drop: Slump in gross margins for major Chinese infant formula players in first six months of 2022

Fonterra eyes booming wellbeing and medical nutrition markets in China, SEA with new portfolio

'Memory care': Megmilk Snow Brand, Kirin co-develop functional drink for Japan's ageing market

'Polypill' progress: Singapore 3D printing personalised nutrition firm prepares overseas entry with new funds

Tapping potential: Indian nutra firm Diabliss to develop 10 new herbal water products

Bubs CEO: Market dynamics mean US infant formula sector will be as significant as China

Related news

Show more

Related products

show more

Change the Cognitive Space with Curcumin

Verdure Sciences | 13-Mar-2023 | Infographic

Globally, 46% of consumers are seeking ways to improve mental wellbeing and are looking to continue to take a proactive and holistic approach to wellness...

Improve joint pain with krill oil phospholipids

Aker BioMarine | 03-Mar-2023 | Technical / White Paper

Krill oil’s beneficial effect on joint health solidified by new large, long-term study.

Seize the opportunities in muscle health

SYNBIO TECH INC. | 02-Mar-2023 | Technical / White Paper

The muscle health category addresses a far greater than sports nutrition and active lifestyle, age-related muscle loss affects 100% of the population.

Pycnogenol® May Be Effective for Managing Pediatric ADHD Without Side Effects

Horphag Research | 06-Feb-2023 | Clinical Study

New research shows Pycnogenol® French maritime pine bark extract may be effective in managing hyperactivity and impulsivity in children aged six to twelve,...

Related suppliers

SYNBIO TECH INC.

Follow us

Products

View more

Webinars

Upcoming supplier webinars

29 Mar 2023 Wed Spotlight on... Ashwagandha: The Superstar Ingredient

Upcoming editorial webinars

29 Mar 2023 Wed Webinar Spotlight on... Ashwagandha: The Superstar Ingredient

On-demand webinars

Nutra Champions Podcast

Nutra Champions Podcast

Headlines

Promotional Features